Results 5,501-5,520 of 5,632 for speaker:Paul McAuliffe

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: I was going to say "Ms Morrogh", but I am very familiar with her from my days on the rare disease task force so it seems quite strange to address her so formally. Perhaps Rachel would outline the feedback from the cancer support line on the impact on the mental health of patients who have already been diagnosed with cancer. Could she outline some of the experiences she has heard about,...

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: To expand on that point, I have been contacted by several people who have rare forms of cancer. They have found the lockdown period very difficult. However, as we emerge from lockdown there is so much uncertainty about how they can safely operate in society and the period for which this will continue is indeterminate. In many ways this is having a more severe impact on their mental health....

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: The submission outlines the need for a clear communications campaign on the signs and symptoms of cancer and to encourage people to attend their healthcare professionals on that. Has there been any positive feedback from the HSE on that? Radio and television are full of advertisements on Covid-19. Has any of that pre-booked advertising been considered to target those who may be developing...

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: Based on what the Irish Cancer Society has been hearing on the cancer support line, what has been the experience for those patients undergoing radiotherapy or chemotherapy treatment who may have suppressed immune response?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: The backlog was discussed earlier. Has the HSE discussed how that backlog may be addressed with either of the organisations? Will it address it purely through the public system, or will it seek short-term capacity from the private system?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: To come back to the point, Dr. McCauley or Dr. Peadar Gilligan mentioned the issue of the flu vaccination. Obviously, in the fight against Covid, a comprehensive and more widespread flu vaccination programme will be needed. I wonder if both organisations, particularly the IMO but also in terms of cancer patients, might comment on what they would like that vaccination programme to look like...

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: Can we hear from the cancer society?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: That point that vaccination saves lives needs to be underscored later on with the HSE as well. We have seen social media used positively, but during this pandemic we have also seen it used negatively in terms of misinformation. I support Ms Clyne's comments on the vaccinations. In terms of the other services the cancer society provides, fund-raising is a huge component, particularly in...

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: Mr. Buggy said there will be a significant deficit. Is he prepared to put a figure on that?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: I had the great pleasure of launching the volunteer driver service for the ICS last year in Beaumont Hospital. What impact has the pandemic had on recruiting volunteers for that service throughout the country?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (17 Jul 2020)

Paul McAuliffe: All members would urge people to support the society in meeting both the financial deficit and the deficit of volunteers in order that it might try to continue to support cancer patients. I thank both organisations for being with us.

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: I refer to the discussions we had this morning with the Irish Cancer Society and the IMO, particularly the discussion about a national flu vaccination programme. Can the witnesses flesh out some of the plans for that? Is that being done in parallel with the fight against Covid-19, particularly, the roll-out to non-prioritised groups?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: Is there a reason the HSE is not approaching the flu vaccination programme with the whole population as the target?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: Is the HSE aiming to have the maximum possible roll-out of the flu vaccine to as many people in the population as we possibly can, or are we limiting that ambition to the target groups, just as we might ordinarily do in a normal year?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: From some of the clinical advice this morning there is talk that the flu season may reach us in September or thereafter. We have very little time to prepare for that. From both a social and an economic perspective, and speaking as a public representative, there is a benefit to reducing all levels of influenza that we can in order to avoid it being mistaken for Covid-19. Even the slightest...

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: When the HSE is coming back to me on that it might also look at the issue of pharmacists. I understand flu vaccination can be availed of in the local pharmacy, but that pharmacist is not able to administer the vaccine in a person's home, for example. That is additional capacity that could provide the greater than normal ability to deliver the flu vaccine and I urge the HSE to consider that....

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: Capacity issues were raised this morning as well. The chief one was the idea of the 500 consultant posts. There was also an alarming enough figure that of the 160 specialised registrars, SpRs, who are exiting rotation this year, only one of them has had an informal consultant post. Can the HSE explain what the delay has been in appointing people to those 500 consultant posts?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: Can I clarify the figure of 526? Is that a net increase?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: My second question was around the greater access to diagnostics for those at primary care or GP level. Can Mr. Woods talk to that issue, please?

Special Committee on Covid-19 Response: Non-Covid Healthcare Disruption: Waiting Lists and Screening (Resumed) (17 Jul 2020)

Paul McAuliffe: When Mr. Woods talks about going to market on diagnostics, does he have a number for the diagnostic machines that can be delivered and the types of machines?